N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI)

Medical Science Monitor

Volumn 17, Issue 12, 2011, Pages

  Walecki, Jerzy ^a   Barcikowska, Maria ^b   Ćwikła, Jaroslaw B ^c   Gabryelewicz, Tomasz ^b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Alzheimer's disease (AD); Mild cognitive impairment (MCI)

Indexed keywords

CHOLINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE;

EID: 82755186407     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882112     Document Type: Article

References (37)

1. Petersen RG, Doody R, Kurz A et al: Current concepts in mild cognitive impairment. Arch Neurol, 2001; 58: 1985-92
2. Petersen RC, Smith GE, Waring SC et al: Ageing, memory and mild cognitive impairment. Int Psychogeriatr, 1997; 9: 65-70
3. Smith GE, Petersen RC, Parisi JE et al: Definition, course and outcome of mild cognitive impairment. Ageing, Neuropsychl & Cognition, 1996; 3: 141-47
4. Gabryelewicz T, Pawlowska-Detko A, Misko J et al: Prediction of deterioration of mild cognitive impairment with CT and SPECT. Med Sci Monit, 2007; 13(Suppl.1): 31-37
5. Modrego PJ, Fayed N, Pina MA: Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain MR spectroscopy. Am J Psychiatry, 2005; 162: 667-75
6. Braak H, Braak E: Neuropathological staging of Alzheimer's disease. Acta Neuropathol (Berl), 1991; 82: 239-59
7. Pantel J, Huger Dr, Kratz B et al: Structural cerebral changes in subjects with mild cognitive impairment. Nervenarzt, 2002; 73: 845-50
8. Chetelat G, Baron JC: Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage, 2003; 18: 525-41
9. Jack CR, Petersen RC, Xu Y et al: Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology, 1997; 49: 786-94
10. Kordower JH, Chu Y, Stebbins GT et al: Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol, 2001; 49: 202-13
11. Du AT, Schuff N, Amend D et al: Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry, 2001; 71: 441-47
12. Czarnecka A, Zimny A, Sa{ogonek}siadek M: Correlation of CT perfusion and CT volumetry in patients with AD. Pol J Radiol, 2010: 75: 15-21
13. Devanand DP, Pradhaban G, Liu X et al: Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology, 2007; 68: 828-36
14. Celsis P, Agneil A, Cardebrat D: Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J Neurol Neurosurg Psychiatry, 1997; 62: 601-8
15. Berent S, Giordani B, Foster N: Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. J Psychiatr Res, 1999; 33: 7-16
16. Bottomley PA: The trouble with spectroscopy papers. Radiology, 1991; 181: 344-50
17. Schuff N, Amend D, Ezekiel F et al: Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology, 1997; 49: 1513-21
18. Block W, Jessen F et al: Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer's disease. Arch Neurol, 2002; 59: 828-34
19. Catani M, Cherubini A, Howard R et al: 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport, 2001; 12: 2315-17
20. Kantarci K, Jack CR, Xu YC et al: Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology, 2000; 55: 210-17
21. Kantarci K, Smith GE, Ivnik RJ et al: 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J International Neuropsychological Society, 2002; 8: 934-42
22. Lazeyras F, Charles HC, Tupler LA et al: Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. Psychiatry Res, 1998; 82: 95-106
23. Adalsteinsson E, Sullivan EV, Kleinhans N et al: Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet, 2000; 355(9216): 1696-97
24. Kantarci K, Reynolds G, Petersen RC et al: Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3T. Am J Neuroradiol, 2003; 24: 843-49
25. Metastasio A, Rinaldi P, Tarducci R et al: Conversion of MCI to dementia: Role of MRS. Neurobiol Aging, 2006; 27: 926-32
26. 1H-MRS in mild cognitive impairment (MCI)-the role of particular metabolites in prediction of MCI conversion to AD. Med Sci Monit, 2010; 16(Suppl.1): 11-18
27. Tarasow E, Kochanowicz J, Mariak Z, Walecki MR: Spectroscopy in patients after surgical clipping and endovascular embolisation of intracranial aneurysms. Pol J Radiol, 2010; 75(4): 25-30
28. Rose SE, de Zubicaray GI, Wang D et al: A 1H MRS study of probably Alzheimer disease and normal aging: implication for longitudinal monitoring of fementia progression. Magn Reson Imaging, 1999; 17: 291-99
29. Martinez-Bisbal MC, Arana E et al: Cognitive impairement classification of 1h MRS. Eur J Neurol, 2004; 11: 187-93
30. 1H MRS study. Am J Psychiatry, 1999; 156: 1879-86
31. DeKosky ST, Ikonomovic MD, Styren SD et al: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol, 2002; 51: 145-55
32. Farber SA, Slack BE, Blusztajn JK: Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease. FASEB J, 2000; 14: 2198-206
33. Nitsch RM, Blusztajn JK, Pittas AG et al: Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci, 1992; 89: 1671-75
34. Kantarci K, Reynolds G, Petersen RC et al: Proton MR spectroscopy in mild cognitive impairment and Alzheimer's disease: comparison of 1,5 and 3 T. Am J Neuroradiol, 2003; 24: 843-49
35. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurol Res, 2004; 26: 488-95
36. Pienia{ogonek}żek P, Sokół M, Walecki J et al: Metodyka badań 1H MRS pojedynczego voxela ludzkiego mózgu in vivo. Diagnostyka Obrazowa, 2002: 1: 13-19 [in Polish]
37. Yuan-Yu H, Chen C et al: Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging. Am J Neuroradiol, 1999; 20: 643-51